This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1988-1997.
Company Filing History:
Years Active: 1988-1997
Title: Albrecht Groner: Pioneering Innovations in Pharmacological Science
Introduction
Albrecht Groner, a distinguished inventor based in Seeheim-Jugenheim, Germany, has made significant contributions to the field of pharmacological compositions and viral propagation techniques. With two patents to his name, Groner's work exemplifies the intersection of innovative science and practical application.
Latest Patents
One of Groner's landmark inventions is a pharmacological composition comprising polyelectrolyte complexes. This invention focuses on a polyacid with an average particle size of less than 15 micrometers, combined with various active agents such as peptides, proteins, enzymes, and antibiotics. The composition ensures that the active agents are converted into a non-deleterious form for administration, enhancing the biodistribution, bioavailability, and absorption of the pharmaceutical agent.
Another notable patent concerns a process for growing Cydia pomonella granulosis virus (CpGV). This innovative method involves propagating the virus in larvae of Tortricidae species that exhibit an LD50 for the virus at a level significantly higher than that of codling moth larvae. This advancement is crucial for improving virus production, which can have implications in biological control strategies.
Career Highlights
Albrecht Groner's work primarily takes place at Hoechst Aktiengesellschaft, a leading company in the field of pharmaceuticals. His research and innovative practices have contributed to the enhancement of therapeutic modalities and the development of effective biological control agents. His dedication to scientific advancement is evident in his carefully crafted inventions that target complex biological challenges.
Collaborations
Groner has worked alongside esteemed colleagues such as Volker Krone and Michael Magerstadt, fostering a collaborative environment that encourages the exchange of ideas and expertise. These partnerships likely enhance the innovation process, leading to groundbreaking discoveries in pharmacology and biotechnology.
Conclusion
Albrecht Groner stands out as a significant inventor whose contributions to pharmacological science and viral processes display profound implications for medical and agricultural applications. Through his patents, he continues to push the boundaries of innovation, proving that dedication to research and collaboration can lead to impactful advancements in science.